These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Progress in the Management of Pregnancy with Paroxysmal Nocturnal Hemoglobinuria: A Review. Zhang B; Chu R; Huang C; Song X; Wang J; Li L; Xu Y; Ma Y J Womens Health (Larchmt); 2024 Jan; 33(1):98-104. PubMed ID: 37917919 [TBL] [Abstract][Full Text] [Related]
23. [Management of pregnancy and delivery in patients with paroxysmal nocturnal hemoglobinuria]. Usuki K Rinsho Ketsueki; 2015 Jul; 56(7):785-94. PubMed ID: 26251141 [TBL] [Abstract][Full Text] [Related]
24. The complement alternative pathway in paroxysmal nocturnal hemoglobinuria: From a pathogenic mechanism to a therapeutic target. Risitano AM; Frieri C; Urciuoli E; Marano L Immunol Rev; 2023 Jan; 313(1):262-278. PubMed ID: 36110036 [TBL] [Abstract][Full Text] [Related]
25. Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs. Girmenia C; Barcellini W; Bianchi P; Di Bona E; Iori AP; Notaro R; Sica S; Zanella A; De Vivo A; Barosi G; Risitano A; Blood Rev; 2023 Mar; 58():101013. PubMed ID: 36117056 [TBL] [Abstract][Full Text] [Related]
26. Update on paroxysmal nocturnal haemoglobinuria: on the long way to understand the principles of the disease. Schubert J; Röth A Eur J Haematol; 2015 Jun; 94(6):464-73. PubMed ID: 25702878 [TBL] [Abstract][Full Text] [Related]
27. How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry. Patriquin CJ; Kiss T; Caplan S; Chin-Yee I; Grewal K; Grossman J; Larratt L; Marceau D; Nevill T; Sutherland DR; Wells RA; Leber B Eur J Haematol; 2019 Jan; 102(1):36-52. PubMed ID: 30242915 [TBL] [Abstract][Full Text] [Related]
29. Effective eculizumab therapy followed by BMT in a boy with paroxysmal nocturnal hemoglobinuria. Oshiro H; Goi K; Akahane K; Inukai T; Sugita K Pediatr Int; 2015 Apr; 57(2):e27-9. PubMed ID: 25868955 [TBL] [Abstract][Full Text] [Related]
30. Renal involvement in paroxysmal nocturnal haemoglobinuria: a brief review of the literature. Macedo ÊS; Parente Filho SLA; Pro JDZ; Rolim VM; Primo GAS; Brunetta DM; Silva HFD; Meneses GC; Barroso-Duarte F; Daher EF Rev Assoc Med Bras (1992); 2018 Dec; 64(12):1139-1146. PubMed ID: 30569992 [TBL] [Abstract][Full Text] [Related]
31. [Paroxysmal nocturnal hemoglobinuria during pregnancy: a case report and literature review]. Wang W; Wang XQ Zhonghua Xue Ye Xue Za Zhi; 2024 Sep; 45(9):861-863. PubMed ID: 39414612 [TBL] [Abstract][Full Text] [Related]
32. Diagnosis and management of PNH: Review and recommendations from a Belgian expert panel. Devos T; Meers S; Boeckx N; Gothot A; Deeren D; Chatelain B; Chatelain C; Devalet B Eur J Haematol; 2018 Dec; 101(6):737-749. PubMed ID: 30171728 [TBL] [Abstract][Full Text] [Related]
33. [Guidelines for the diagnosis and management of paroxysmal nocturnal hemoglobinuria (2024)]. Red Blood Cell Disease (Anemia) Group, Chinese Society of Hematology, Chinese Medical Association Zhonghua Xue Ye Xue Za Zhi; 2024 Aug; 45(8):727-737. PubMed ID: 39307719 [TBL] [Abstract][Full Text] [Related]
34. Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3. Risitano AM; Perna F; Selleri C Mini Rev Med Chem; 2011 Jun; 11(6):528-35. PubMed ID: 21561403 [TBL] [Abstract][Full Text] [Related]
35. Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria. Hill A; Richards SJ; Hillmen P Br J Haematol; 2007 May; 137(3):181-92. PubMed ID: 17408457 [TBL] [Abstract][Full Text] [Related]
36. Dosing Patterns of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab in the United States: A Retrospective Claims-Based Analysis. Cheng WY; Fishman J; Yenikomshian M; Mahendran M; Kunzweiler C; Vu JD; Duh MS Adv Ther; 2024 Jan; 41(1):413-430. PubMed ID: 37999832 [TBL] [Abstract][Full Text] [Related]
37. Successful treatment of a PNH patient non-responsive to eculizumab with the novel complement C5 inhibitor coversin (nomacopan). Schols S; Nunn MA; Mackie I; Weston-Davies W; Nishimura JI; Kanakura Y; Blijlevens N; Muus P; Langemeijer S Br J Haematol; 2020 Jan; 188(2):334-337. PubMed ID: 31840801 [No Abstract] [Full Text] [Related]
38. COVID-19 Presented with Deep Vein Thrombosis in a Patient with Paroxysmal Nocturnal Haemoglobinuria. Pravdic Z; Mitrovic M; Bogdanovic A; Virijevic M; Sabljic N; Pantic N; Vukovic NS Hamostaseologie; 2021 Oct; 41(5):397-399. PubMed ID: 34544179 [TBL] [Abstract][Full Text] [Related]
39. Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab. Cooper JP; Farah RJ; Stevenson PA; Gooley TA; Storb R; Scott BL Biol Blood Marrow Transplant; 2019 Jul; 25(7):1331-1339. PubMed ID: 30711779 [TBL] [Abstract][Full Text] [Related]
40. The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab. Kelly R; Arnold L; Richards S; Hill A; Bomken C; Hanley J; Loughney A; Beauchamp J; Khursigara G; Rother RP; Chalmers E; Fyfe A; Fitzsimons E; Nakamura R; Gaya A; Risitano AM; Schubert J; Norfolk D; Simpson N; Hillmen P Br J Haematol; 2010 May; 149(3):446-50. PubMed ID: 20151973 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]